SPI Infoamtion

Table of Contents

Executive summary

Overview of emerging markets for pharmaceuticals
Emerging market profiles by countries and regions
Emerging market growth strategies by leading companies
Emerging market opportunities by product segment
Recommendations for success in emerging markets

Chapter 1 Overview of emerging markets for pharmaceuticals

Summary
Introduction
Pharmerging countries

2007 forecast
2008 forecast

Multiple classifications of emerging markets
China is the largest growth opportunity
Emerging market opportunities
Emerging market challenges

Chapter 2 Emerging market profiles by country and regions

Summary
Brazil

Market size and forecast
Demographics
Opportunities and challenges
Recent acquisitions and alliances

China

Market size and forecast
Demographics
Overview
Market segments
Opportunity: China's healthcare expansion plan
Impact of Chinese healthcare reforms
Additional opportunities and challenges
China market segmentation: Tier 1, 2 and 3 cities
Leading industry company strategies in China
Recent acquisitions and alliances

India

Market size and forecast
Demographics
Overview
Opportunities and challenges
Leading industry company strategies
Recent acquisitions and alliances

South Korea

Market size and forecast
Demographics
Leading industry company strategies

Mexico

Market size and forecast
Demographics
Leading industry company strategies
Recent acquisitions and alliances

Russia

Market size and forecast
Demographics
HIV prevalence
Market overview
Opportunities and challenges
Leading industry company strategies
Recent acquisitions and alliances

Turkey

Market size and forecast
Demographics
Market overview
Opportunities and challenges
Leading industry company strategies
Recent acquisitions and alliances

Other emerging Asia-Pacific markets

Demographics
Opportunities and challenges
Leading industry company strategies

Other emerging Latin America markets

Demographics
Leading industry company strategies
Recent acquisitions and alliances

Other emerging Central and Eastern European markets

Demographics
Leading industry company strategies
Recent acquisitions and alliances

Other emerging Middle East and Africa markets

Chapter 3 Emerging market growth strategies by leading companies

Summary
Abbott
AstraZeneca
Bristol Myers Squibb
Bayer
Boehringer Ingelheim
Daiichi Sankyo
Eisai
GSK

Generics
Vaccines
HIV Agents
Asia-Pacific
China
India
Developing world initiatives

J&J
Lilly
Merck

China
Developing world initiatives

Mylan
Novartis

Generics
China

Novo Nordisk
Pfizer

Generics
China
Innovative strategies

Roche
Sanofi-Aventis
Takeda
Teva

Chapter 4 Emerging market opportunities by product segment

Summary
Patented and innovative products
Generics/branded generics
Biosimilars
OTCs
HIV and hepatitis agents

HIV agents
Hepatitis agents

Vaccines

Industry vaccine leaders
Opportunities
Challenges
Recent vaccine acquisitions and alliances

Developing world vaccines and medicines

Developing market disease numbers

Chapter 5 Recommendations for success in emerging markets

Summary
Product offering
Country selection
Partnerships
Strategy development
Competitor awareness
Tailor marketing to the market
Market "glocally"
Effective promotion
Region specific planning
Security risks

Security of data and manufacturing supply chain
Protection of company image and reputation
Protection of assets

Index
Appendix
References

List of Figures
Figure 1.1: 2013 forecast of seven emerging markets ($bn), 2008-2013
Figure 5.2: Product opportunities

List of Tables
Table 1.1: 2013 forecast of seven emerging markets, 2009
Table 1.2: 2008 sales in the seven major emerging markets, 2009
Table 1.3: Prevalence of diabetes (m), 2000-2030
Table 2.4: Statistics: Seven major seven emerging pharmaceutical markets
Table 2.5: Tier 1, 2 and 3 Chinese cities, 2008
Table 2.6: Other emerging Asia-Pacific Markets: Statistics
Table 2.7: Diabetics (millions)
Table 2.8: Other emerging Latin America Markets: Statistics
Table 2.9: Other emerging Central and Eastern European markets: statistics
Table 4.10: Marketed and pipeline biosimilars by company
Table 4.11: Annual deaths due to HIV/AIDS by country
Table 4.12: HIV prevalence (millions), 2007
Table 4.13: Select companies with vaccines by type